Kazmira Therapeutics Email Format

Pharmaceutical ManufacturingUnited States11-50 Employees

Trusted Prescription-Grade Cannabinoid Therapy.

Kazmira is a prescription-first cannabinoid therapy platform, built for the healthcare system—not the wellness aisle. Operating under licensed 503A pharmacy standards, we’re authorized to compound THC-free CBD isolate as an active pharmaceutical ingredient (API).

These therapies aren’t shelf-ready products—they’re patient-specific solutions made to exacting pharmacy standards, rigorously tested, and delivered through a HIPAA-secure, eRx-to-door workflow. By replacing retail guesswork with medical oversight, condition-specific protocols, and provider partnership, Kazmira restores clinical trust in cannabinoid care—real medicine without the stigma or recreational noise.

Sign up for free to view info

Company overview Employee directory